Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis (Q44259982)

1 December 2017

Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis (English)

1 reference

1 December 2017

Susan E Moody

1

1 reference

1 December 2017

Christopher J Sarkisian

2

1 reference

1 December 2017

Kristina T Hahn

3

1 reference

1 December 2017

Edward J Gunther

4

1 reference

1 December 2017

Steven Pickup

5

1 reference

1 December 2017

Katherine D Dugan

6

1 reference

1 December 2017

Nathalie Innocent

7

1 reference

1 December 2017

Robert D Cardiff

8

1 reference

1 December 2017

Mitchell D Schnall

9

1 reference

1 December 2017

Lewis A Chodosh

10

1 reference

1 December 2017

1 December 2002

1 reference

1 December 2017

1 reference

1 December 2017

2

1 reference

1 December 2017

451-461

1 reference

1 December 2017

6

1 reference

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

The comparative pathology of human and mouse mammary glands

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Essential role for oncogenic Ras in tumour maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Reversible tumorigenesis by MYC in hematopoietic lineages

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

HER2 overexpression and cancer targeting

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

Targeting HER2: recent developments and future directions for breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900212-X

7 January 2021

10.1016/S1535-6108(02)00212-X

Identifiers

DOI

1 reference

1 December 2017

1 reference